List of Tables
Table 1. Global Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Extracellular Signal-Regulated Kinase Signaling Pathway
Table 3. Key Players of C-Jun N-Terminal Kinase/Stress-Activated Protein Signaling Pathway
Table 4. Key Players of P38 MAPK Signaling Pathway
Table 5. Key Players of ERK5/Macromitogen-Activated Protein Kinase Signaling Pathway
Table 6. Global Mitogen-Activated Protein Kinase Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mitogen-Activated Protein Kinase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mitogen-Activated Protein Kinase Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Region (2020-2025)
Table 10. Global Mitogen-Activated Protein Kinase Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Region (2026-2031)
Table 12. Mitogen-Activated Protein Kinase Inhibitors Market Trends
Table 13. Mitogen-Activated Protein Kinase Inhibitors Market Drivers
Table 14. Mitogen-Activated Protein Kinase Inhibitors Market Challenges
Table 15. Mitogen-Activated Protein Kinase Inhibitors Market Restraints
Table 16. Global Mitogen-Activated Protein Kinase Inhibitors Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Players (2020-2025)
Table 18. Global Top Mitogen-Activated Protein Kinase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitogen-Activated Protein Kinase Inhibitors as of 2024)
Table 19. Ranking of Global Top Mitogen-Activated Protein Kinase Inhibitors Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mitogen-Activated Protein Kinase Inhibitors Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mitogen-Activated Protein Kinase Inhibitors, Headquarters and Area Served
Table 22. Global Key Players of Mitogen-Activated Protein Kinase Inhibitors, Product and Application
Table 23. Global Key Players of Mitogen-Activated Protein Kinase Inhibitors, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mitogen-Activated Protein Kinase Inhibitors Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share by Type (2020-2025)
Table 27. Global Mitogen-Activated Protein Kinase Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share by Type (2026-2031)
Table 29. Global Mitogen-Activated Protein Kinase Inhibitors Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share by Application (2020-2025)
Table 31. Global Mitogen-Activated Protein Kinase Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share by Application (2026-2031)
Table 33. North America Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mitogen-Activated Protein Kinase Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mitogen-Activated Protein Kinase Inhibitors Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 48. GEn1E Lifesciences Inc Company Details
Table 49. GEn1E Lifesciences Inc Business Overview
Table 50. GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Product
Table 51. GEn1E Lifesciences Inc Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 52. GEn1E Lifesciences Inc Recent Development
Table 53. F. Hoffmann-La Roche Ltd Company Details
Table 54. F. Hoffmann-La Roche Ltd Business Overview
Table 55. F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Product
Table 56. F. Hoffmann-La Roche Ltd Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 57. F. Hoffmann-La Roche Ltd Recent Development
Table 58. Lilly Company Details
Table 59. Lilly Business Overview
Table 60. Lilly Mitogen-Activated Protein Kinase Inhibitors Product
Table 61. Lilly Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 62. Lilly Recent Development
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Product
Table 66. AstraZeneca Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Merck & Co., Inc Company Details
Table 69. Merck & Co., Inc Business Overview
Table 70. Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Product
Table 71. Merck & Co., Inc Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 72. Merck & Co., Inc Recent Development
Table 73. HepaRegeniX GmbH Company Details
Table 74. HepaRegeniX GmbH Business Overview
Table 75. HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Product
Table 76. HepaRegeniX GmbH Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 77. HepaRegeniX GmbH Recent Development
Table 78. GSK plc Company Details
Table 79. GSK plc Business Overview
Table 80. GSK plc Mitogen-Activated Protein Kinase Inhibitors Product
Table 81. GSK plc Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 82. GSK plc Recent Development
Table 83. Mereo Biopharma Group PLC Company Details
Table 84. Mereo Biopharma Group PLC Business Overview
Table 85. Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Product
Table 86. Mereo Biopharma Group PLC Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 87. Mereo Biopharma Group PLC Recent Development
Table 88. Kura Oncology, Inc Company Details
Table 89. Kura Oncology, Inc Business Overview
Table 90. Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Product
Table 91. Kura Oncology, Inc Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 92. Kura Oncology, Inc Recent Development
Table 93. eFFECTOR Therapeutics, Inc Company Details
Table 94. eFFECTOR Therapeutics, Inc Business Overview
Table 95. eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Product
Table 96. eFFECTOR Therapeutics, Inc Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 97. eFFECTOR Therapeutics, Inc Recent Development
Table 98. Selleck Company Details
Table 99. Selleck Business Overview
Table 100. Selleck Mitogen-Activated Protein Kinase Inhibitors Product
Table 101. Selleck Revenue in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025) & (US$ Million)
Table 102. Selleck Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Mitogen-Activated Protein Kinase Inhibitors Picture
Figure 2. Global Mitogen-Activated Protein Kinase Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Type: 2024 VS 2031
Figure 4. Extracellular Signal-Regulated Kinase Signaling Pathway Features
Figure 5. C-Jun N-Terminal Kinase/Stress-Activated Protein Signaling Pathway Features
Figure 6. P38 MAPK Signaling Pathway Features
Figure 7. ERK5/Macromitogen-Activated Protein Kinase Signaling Pathway Features
Figure 8. Global Mitogen-Activated Protein Kinase Inhibitors Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Application: 2024 VS 2031
Figure 10. Colon Cancer Case Studies
Figure 11. Acute Myelogenous Leukemia Case Studies
Figure 12. Malignant Melanoma Case Studies
Figure 13. Pancreatic Cancer Case Studies
Figure 14. Breast Cancer Case Studies
Figure 15. Other Case Studies
Figure 16. Mitogen-Activated Protein Kinase Inhibitors Report Years Considered
Figure 17. Global Mitogen-Activated Protein Kinase Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Mitogen-Activated Protein Kinase Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Region: 2024 VS 2031
Figure 20. Global Mitogen-Activated Protein Kinase Inhibitors Market Share by Players in 2024
Figure 21. Global Top Mitogen-Activated Protein Kinase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitogen-Activated Protein Kinase Inhibitors as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Mitogen-Activated Protein Kinase Inhibitors Revenue in 2024
Figure 23. North America Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Mitogen-Activated Protein Kinase Inhibitors Market Share by Country (2020-2031)
Figure 25. United States Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Mitogen-Activated Protein Kinase Inhibitors Market Share by Country (2020-2031)
Figure 29. Germany Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Mitogen-Activated Protein Kinase Inhibitors Market Share by Region (2020-2031)
Figure 37. China Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Mitogen-Activated Protein Kinase Inhibitors Market Share by Country (2020-2031)
Figure 45. Mexico Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Market Share by Country (2020-2031)
Figure 49. Turkey Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Mitogen-Activated Protein Kinase Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. GEn1E Lifesciences Inc Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 53. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 54. Lilly Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 56. Merck & Co., Inc Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 57. HepaRegeniX GmbH Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 58. GSK plc Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 59. Mereo Biopharma Group PLC Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 60. Kura Oncology, Inc Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 61. eFFECTOR Therapeutics, Inc Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 62. Selleck Revenue Growth Rate in Mitogen-Activated Protein Kinase Inhibitors Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
